Dori Di Bella

Medical Publications | Haematology & Oncology

United Kingdom

About

As Medical Publications Manager and Medical Writer, I contribute to impactful scientific publication strategies in several therapeutic areas.

Experience

  • Medical Writer at Helios Global Group
    Jul 2025 - Present · 1 yr 1 mo

    Oncology | Neurology Publications & Medical Affairs

  • Excerpta Medica BV - Adelphi Group (Hybrid)
    • Medical Publications Manager
      Mar 2025 - Jul 2025 · 5 mos

    • Associate Medical Publications Manager
      Jun 2023 - Feb 2025 · 1 yr 9 mos

      Rare diseases | Respiratory | Dermatology | Haemato-oncology • Managed and produced scientific publication projects, including clinical manuscripts, abstract, congress presentations, global response documents and medical information letters • Led project calls with pharmaceutical and biotech clients, ensuring alignment on project scope and content direction • Contributed to the development of publication strategies

  • Medical Writer at Bioscope Health
    Oct 2022 - May 2023 · 8 mos

  • Medical Writer at Random42 Scientific Communication
    Jan 2022 - Jun 2022 · 6 mos

    • Developed scientific content for medical education, scientific conferences, and pharmaceutical advertising, including slide decks, video animations, interactive experiences and virtual reality, for several audiences, and across various therapeutic areas. • Collaborated with pharmaceutical and biotech clients to define project scope and timelines, and engaged in cross-functional teamwork

  • Barts Cancer Institute (Greater London, England, United Kingdom · On-site)
    • Doctoral Research Scientist in Haemato-Oncology
      Oct 2018 - Dec 2021 · 3 yrs 3 mos

      • Conducted research on endoplasmic reticulum stress in the bone marrow microenvironment of acute myeloid leukaemia (AML). • Developed and optimized experimental assays, including flow cytometry, multi-omic analyses (RNA-seq, proteomics and phospho-proteomics) and genetically modified primary cells, to identify alterations within the tumour microenvironment and model pathogenic mechanisms

    • Research Scientist in Haemato-Oncology
      Jan 2018 - Oct 2018 · 10 mos

      • Conducted research on the genetics of familial and sporadic acute myeloid leukaemia (AML) • Developed in vitro and in vivo models to study genetic variants linked to familial AML using CRISPR/Cas9 gene editing. • Executed large-scale multi-omic profiling of AML patient samples, identifying potential biomarkers for personalized treatment. • Collaborated with a multidisciplinary team, enhancing the understanding of AML and improving patient outcomes.

    • Research Intern in Oncology & Immunology
      Mar 2017 - Dec 2017 · 10 mos

      • Conducted a 9-month research project on Notch-1 signalling in cancer resistance to monoclonal antibody therapies • Established and validated a lentiviral reporters to monitor activity in response to therapies. • Awarded an Erasmus+ Traineeship scholarship for international research experience.